FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely ophthalmology, and is intended for the prevention or treatment of dry eyes. To prevent or treat dry eyes, a compound corresponding to formula I, its optical isomer or its pharmacologically acceptable salt is used as an effective component, while the values of radicals in formula I are the same as indicated in point 1 of the invention formula. Also, a method for treating dry eyes is presented, including the introduction of a therapeutically effective amount of this compound. In addition, the use of this compound is provided for the manufacture of a drug for the treatment of dry eyes.
EFFECT: use of the group of inventions makes it possible to increase the effectiveness of the treatment of dry eyes.
[Formula I]
10 cl, 3 dwg, 14 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION INCLUDING A HISTONE DEACETYLASE INHIBITOR AND METHOTREXATE | 2019 |
|
RU2772018C1 |
| COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | 2020 |
|
RU2798874C1 |
| COMPOUNDS FOR TREATING CANCER | 2015 |
|
RU2733393C2 |
| COMPOSITIONS FOR PREVENTION OR TREATMENT OF UVEITIS | 2019 |
|
RU2757273C1 |
| COMPOUNDS FOR TREATMENT OF CANCER | 2015 |
|
RU2805949C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| COMPOSITIONS FOR PREVENTION OR TREATMENT OF LUPUS | 2018 |
|
RU2757014C1 |
| COMPOUNDS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER AND OVARIAN CANCER | 2019 |
|
RU2776897C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING TUMOUR | 2010 |
|
RU2577700C2 |
| COMPOSITION FOR TREATING DISORDERS OF EXTERNAL SECRETION | 2000 |
|
RU2264816C2 |
